Anti-Angiogenic Therapies in the Treatment of Waldenstrom's Macroglobulinemia
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
1025-1029
Author(s):
A. Sacco, I. M. Ghobrial and A. M. Roccaro
Antiangiogenesis in Myelodysplastic Syndrome
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
1044-1052
Author(s):
A. Aguayo, F. M. Armillas-Canseco and D. Martinez-Banos
Effective Treatment of Human Lung Cancer by Targeting Tissue Factor with a Factor VII-Targeted Photodynamic Therapy
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
1069-1081
Author(s):
J. Cheng, J. Xu, J. Duanmu, H. Zhou, C. J. Booth and Z. Hu
EphA2-Dependent Molecular Targeting Therapy for Malignant Tumors
Journal:
Current Cancer Drug Targets
Volume:
11
Page:
1082-1097
Author(s):
RONG Biao-xue, CAI Xi-guang, YANG Shuan-ying, LI Wei and MING Zong-juan
Hepatoma-Derived Growth Factor in Carcinogenesis and Cancer Progression
Journal:
Current Drug Therapy
Volume:
6
Page:
278-285
Author(s):
Hideji Nakamura and Hirayuki Enomoto
Mast Cells and Basophils: Trojan Horses of Conventional Lin- Stem/Progenitor Cell Isolates
Journal:
Current Pharmaceutical Design
Volume:
17
Page:
3753-3771
Author(s):
Petr Heneberg
Key Questions in Metastasis: New Insights in Molecular Pathways and Therapeutic Implications
Journal:
Current Pharmaceutical Biotechnology
Volume:
12
Page:
1867-1880
Author(s):
G. Gueron, A. De Siervi and E. Vazquez
Is the Epithelial-to-Mesenchymal Transition Clinically Relevant for the Cancer Patient?
Journal:
Current Pharmaceutical Biotechnology
Volume:
12
Page:
1891-1899
Author(s):
Martin A. Krasnapolski, Laura B. Todaro and Elisa Bal de Kier Joffe
Metastatic Cancer Stem Cells: New Molecular Targets for Cancer Therapy
Journal:
Current Pharmaceutical Biotechnology
Volume:
12
Page:
1909-1922
Author(s):
G. J. Leiros and M. E. Balana
Tumor Immune Escape Mechanisms that Operate During Metastasis
Journal:
Current Pharmaceutical Biotechnology
Volume:
12
Page:
1923-1936
Author(s):
D. O. Croci and M. Salatino